Medyssey Co., Ltd. announced that it has received KRW 4 billion in funding from NongHyup Bank, Investment Arm, and IBK Capital Corporation.
May 31, 2016
Share
Medyssey Co., Ltd. announced a private placement of 216,216 convertible, redeemable and interest callable preferred shares at a price of KRW 18,500 per share for gross proceeds of KRW 3,999,996,000 on May 31, 2016. The transaction included participation from new investors, IBK Financial Group KONEX Investment Fund, a fund managed by IBK Capital Corporation, which will subscribe 108,108 shares, and Nonghyup Bank, Investment Arm, which will subscribe 108,108 shares. The transaction has been approved by the board of directors of the company. The preferred shares are convertible into common shares of the company. The conversion period will start on June 1, 2016 and will end on May 31, 2016. The transaction took place through third party allotment.
MEDYSSEY CO.,LTD is a Korea-based company mainly engaged in the manufacture of orthopedic spinal implants. The Company's product portfolio consists of spinal fixation systems that used for lumbar and lumbosacral degenerative pathologies, semi-rigid systems, posterior lumbar interbody fusion (PLIF) cages, PLIF expandable cages, porous cages, transforaminal lumbar interbody fusion (TLIF) cages, cervical plates, cervical cages, high tibial osteotomy systems, pectus bars, omega fixation systems, inter-spinous devices and others.
MEDYSSEY CO.,LTD 
